Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Oxitec

Oxitec

Oxitec's non-biting male mosquito was designed to control invasive, disease spreading Aedes aegypti. It has successfully provided significant suppression of the Aedes aegypti in other geographies and does not persist in the environment or cause harm to beneficial insects such as bees and butterflies. This technology also removes all requirements for adult mosquito-rearing and releases and eliminates the potential for female releases. Combined with other innovations, this technology is anticipated to reduce up to 90% of costs associated with traditional insect release programs. Similar projects in the Brazilian city of Indaiatuba found that Oxitec's male mosquito suppressed disease-carrying Aedes aegypti by up to 95%[1] in urban, dengue-prone environments following just 13 weeks of treatment, as compared to untreated control sites in the same city.

Last updated on

About Oxitec

Founded

2002

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$35M

Category

Industry

Biotechnology

Location

City

Abingdon

State

Oxfordshire

Country

United Kingdom

Tech Stack (66)

search